September 9, 2014 — Cook Medical has enrolled the first patient in the clinical study in China of its Zilver PTX Drug ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.
September 8, 2014 — The U.S, Food and Drug Administration (FDA) has cleared MicroVention Inc.’s Low-Profile Visualized ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
September 3, 2014 — Jobst Vascular Institute is conducting pioneering research that looks at using stents to treat ...
August 28, 2014 — Renal artery stenting to open blockages in the kidney arteries may benefit patients who have ...
August 15, 2014 — OrbusNeich announced first patient enrollment in the Randomized Evaluation of short-term Dual anti ...
August 8, 2014 — Biotronik announced the completion of patient enrollment in the superficial femoral artery (SFA) arm of ...
August 7, 2014 — Tryton Medical Inc. announced that the first patient has been enrolled in the EXTENDED Access Registry ...
July 30, 2014 — OrbusNeich announced the first patient has been enrolled in the Multinational Abluminal Sirolimus Coated ...
July 22, 2014 — Boston Scientific announced it received U.S. Food and Drug Administration (FDA) approval for the Rebel ...
July 15, 2014 — Micell Technologies Inc. announced the United States Patent and Trademark Office (USPTO) has issued a ...
July 10, 2014 — 480 Biomedical announced it has been awarded Phase II funding from the National Heart, Lung, and Blood ...
A big fly in the ointment for widespread adoption of many new technologies is cost. In today’s cost-conscience ...
A big fly in the ointment for widespread adoption of many new technologies is cost. In today’s cost-conscience ...